Key Details
Price
$1.04Annual ROE
-171.09%Beta
0.77Events Calendar
Next earnings date:
Feb 14, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Sept 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Estrella Immunopharma doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of Estrella Immunopharma?
- What is the ticker symbol for Estrella Immunopharma?
- Does Estrella Immunopharma pay dividends?
- What sector is Estrella Immunopharma in?
- What industry is Estrella Immunopharma in?
- What country is Estrella Immunopharma based in?
- When did Estrella Immunopharma go public?
- Is Estrella Immunopharma in the S&P 500?
- Is Estrella Immunopharma in the NASDAQ 100?
- Is Estrella Immunopharma in the Dow Jones?
- When was Estrella Immunopharma's last earnings report?
- When does Estrella Immunopharma report earnings?
What is the primary business of Estrella Immunopharma?
Estrella Immunopharma (ESLA) is a biotechnology company focused on developing innovative treatments for autoimmune diseases and cancer. They use advanced technologies to create therapies that improve patients' lives by targeting the immune system and enhancing its ability to fight diseases.
What is the ticker symbol for Estrella Immunopharma?
The ticker symbol for Estrella Immunopharma is NASDAQ:ESLA
Does Estrella Immunopharma pay dividends?
No, Estrella Immunopharma does not pay dividends
What sector is Estrella Immunopharma in?
Estrella Immunopharma is in the Healthcare sector
What industry is Estrella Immunopharma in?
Estrella Immunopharma is in the Biotechnology industry
What country is Estrella Immunopharma based in?
Estrella Immunopharma is headquartered in United States
When did Estrella Immunopharma go public?
Estrella Immunopharma's initial public offering (IPO) was on 14 September 2021
Is Estrella Immunopharma in the S&P 500?
No, Estrella Immunopharma is not included in the S&P 500 index
Is Estrella Immunopharma in the NASDAQ 100?
No, Estrella Immunopharma is not included in the NASDAQ 100 index
Is Estrella Immunopharma in the Dow Jones?
No, Estrella Immunopharma is not included in the Dow Jones index
When was Estrella Immunopharma's last earnings report?
Estrella Immunopharma's most recent earnings report was on 14 November 2024
When does Estrella Immunopharma report earnings?
The next expected earnings date for Estrella Immunopharma is 14 February 2025